Back to Authors

Clausen, Michael Roost

https://orcid.org/0000-0003-3218-3633

A5007011861 | I4210091196

Mayo Clinic

Vejle Sygehus

Citations 12

PRE‐TREATMENT HEMOGLOBIN AND OUTCOME IN PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA TREATED WITH ANTHRACYCLINE CONTAINING CHEMOTHERAPY

Hematological Oncology | June 12, 2019 | Volume: 37 | Issue: S2 | Pages: 418-420

10.1002/hon.88_2631

Up-front rituximab maintenance improves outcome in patients with follicular lymphoma: a collaborative Nordic study

Blood Advances | July 5, 2018 | Volume: 2 | Issue: 13 | Pages: 1562-1571

10.1182/bloodadvances.2018017673 | PMID 29976619

Key PointsPatients who received R-chemo followed by MR had an improved 5-year PFS and OS independent of prognostic factors. A reduction of the risk of HT was observed among the MR patients of the training, but not of the validation, cohort.